Kbc Group Nv Edwards Lifesciences Corp Transaction History

Kbc Group Nv

$36.3 Billion
Q4 2024

A detailed history of Kbc Group Nv transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Kbc Group Nv holds 647,842 shares of EW stock, worth $44.7 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

647,842

Previous 896,162 27.71%

Holding current value

$44.7 Million

Previous $59.1 Million 18.9%

% of portfolio

0.13%

Previous 0.18%

38 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$64.54 - $75.92 $16 Million - $18.9 Million	-248,320 Reduced 27.71%	647,842 $48 Million
Q3 2024 Nov 06, 2024	BUY	$59.7 - $93.78 $6.24 Million - $9.8 Million	104,499 Added 13.2%	896,162 $59.1 Million
Q2 2024 Jul 17, 2024	BUY	$84.3 - $94.31 $4.45 Million - $4.98 Million	52,846 Added 7.15%	791,663 $73.1 Million
Q1 2024 May 08, 2024	SELL	$72.54 - $95.56 $59.3 Million - $78.2 Million	-817,836 Reduced 52.54%	738,817 $70.6 Million
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $1.12 Million - $1.42 Million	-18,226 Reduced 1.16%	1,556,653 $119 Million
Q3 2023 Feb 15, 2024	BUY	$69.28 - $93.38 $12.4 Million - $16.8 Million	179,398 Added 11.32%	1,763,649 $122 Million
Q2 2023 Feb 15, 2024	BUY	$81.41 - $94.33 $37.4 Million - $43.4 Million	459,871 Added 40.9%	1,584,251 $149 Million
Q2 2023 Jul 28, 2023	BUY	$81.41 - $94.33 $27.5 Million - $31.8 Million	337,213 Added 27.25%	1,574,879 $149 Million
Q1 2023 Feb 14, 2024	BUY	$74.26 - $84.51 $20.5 Million - $23.3 Million	275,999 Added 28.48%	1,245,043 $103 Million
Q1 2023 May 04, 2023	BUY	$74.26 - $84.51 $9.16 Million - $10.4 Million	123,403 Added 11.07%	1,237,666 $102 Million
Q4 2022 Feb 14, 2024	SELL	$68.3 - $87.44 $3.63 Million - $4.64 Million	-53,120 Reduced 5.2%	969,044 $72.3 Million
Q3 2022 Feb 15, 2024	SELL	$82.37 - $107.29 $35.6 Million - $46.4 Million	-432,273 Reduced 27.77%	1,124,380 $92.9 Million
Q3 2022 Nov 08, 2022	BUY	$82.37 - $107.29 $8.58 Million - $11.2 Million	104,105 Added 10.31%	1,114,263 $92.1 Million
Q2 2022 Feb 14, 2024	BUY	$86.5 - $128.27 $31 Million - $45.9 Million	358,045 Added 53.91%	1,022,164 $97.2 Million
Q2 2022 Jul 26, 2022	BUY	$86.5 - $128.27 $29.9 Million - $44.4 Million	346,039 Added 52.1%	1,010,158 $96.1 Million
Q1 2022 Feb 14, 2024	SELL	$101.96 - $128.34 $37.4 Million - $47 Million	-366,482 Reduced 35.56%	664,119 $78.2 Million
Q1 2022 May 06, 2022	SELL	$101.96 - $128.34 $37.4 Million - $47 Million	-366,482 Reduced 35.56%	664,119 $78.2 Million
Q4 2021 Feb 14, 2024	SELL	$106.37 - $130.68 $56 Million - $68.7 Million	-526,052 Reduced 33.79%	1,030,601 $134 Million
Q4 2021 Feb 03, 2022	SELL	$106.37 - $130.68 $21.8 Million - $26.8 Million	-204,989 Reduced 16.59%	1,030,601 $134 Million
Q3 2021 Nov 10, 2021	BUY	$102.91 - $122.75 $9.02 Million - $10.8 Million	87,685 Added 7.64%	1,235,590 $140 Million
Q2 2021 Aug 11, 2021	SELL	$83.84 - $104.76 $1.67 Million - $2.08 Million	-19,900 Reduced 1.7%	1,147,905 $119 Million
Q1 2021 Apr 26, 2021	BUY	$78.68 - $90.67 $6.57 Million - $7.58 Million	83,557 Added 7.71%	1,167,805 $97.7 Million
Q4 2020 Feb 10, 2021	BUY	$71.69 - $91.23 $9.82 Million - $12.5 Million	136,961 Added 14.46%	1,084,248 $98.9 Million
Q3 2020 Feb 14, 2022	SELL	$67.19 - $87.44 $806,280 - $1.05 Million	-12,000 Reduced 1.25%	947,287 $75.6 Million
Q3 2020 Oct 28, 2020	BUY	$67.19 - $87.44 $320,697 - $417,351	4,773 Added 0.5%	959,287 $76.6 Million
Q2 2020 Feb 14, 2022	SELL	$57.54 - $76.95 $690,480 - $923,400	-12,000 Reduced 1.24%	954,514 $66 Million
Q2 2020 Aug 10, 2020	BUY	$57.54 - $76.95 $38.1 Million - $50.9 Million	662,075 Added 217.47%	966,514 $66.8 Million
Q1 2020 May 04, 2020	BUY	$52.41 - $81.0 $6.2 Million - $9.58 Million	118,297 Added 63.55%	304,439 $57.4 Million
Q4 2019 Feb 11, 2020	BUY	$71.7 - $82.09 $892,736 - $1.02 Million	12,451 Added 7.17%	186,142 $43.4 Million
Q3 2019 Nov 07, 2019	BUY	$61.55 - $75.43 $298,209 - $365,458	4,845 Added 2.87%	173,691 $12.7 Million
Q2 2019 Jul 30, 2019	BUY	$55.74 - $64.41 $1.73 Million - $2 Million	31,066 Added 22.55%	168,846 $0
Q1 2019 May 10, 2019	SELL	$47.89 - $64.05 $1.87 Million - $2.5 Million	-39,091 Reduced 22.1%	137,780 $0
Q4 2018 Jan 31, 2019	SELL	$46.41 - $56.94 $5.4 Million - $6.62 Million	-116,311 Reduced 39.67%	176,871 $9.03 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $3.2 Million - $4.06 Million	70,018 Added 31.38%	293,182 $0
Q2 2018 Aug 03, 2018	BUY	$42.45 - $51.3 $3.95 Million - $4.78 Million	93,106 Added 71.59%	223,164 $0
Q1 2018 May 09, 2018	BUY	$37.19 - $47.45 $501,507 - $639,863	13,485 Added 11.57%	130,058 $0
Q4 2017 Feb 07, 2018	SELL	$33.79 - $39.39 $12,569 - $14,653	-372 Reduced 0.32%	116,573 $0
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $4.24 Million - $4.54 Million	116,945	116,945 $0

Others Institutions Holding EW

# of Institutions

1,352

Shares Held

469M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $42.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account